A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I, Xia CW, Besoiu S, Finkel PL, Ellis SLS, Kari S, Munro L, Pfeifer CG, Fazli L, Gleave ME, Jefferies WA.
Saranchova I, et al. Among authors: pfeifer cg.
Front Immunol. 2024 Mar 7;15:1317522. doi: 10.3389/fimmu.2024.1317522. eCollection 2024.
Front Immunol. 2024.
PMID: 38524132
Free PMC article.